Table 2.

Percentage of common comorbidities in noncancer controls and cancer survivors (by age and cancer site)a

Noncancer (n = 100,000)All sites (n = 457,659)BladderCRCFemale breastLeukemiaLungOralProstate
Age% with condition(% without)% with condition(% without)% with condition% with condition% with condition% with condition% with condition% with condition% with condition
CHF
 66–69 y4%(96%)6%(94%)6%7%3%7%10%6%4%
 70–74 y6%(94%)8%(92%)9%10%5%9%12%7%5%
 75–79 y8%(92%)11%(89%)11%12%7%13%15%10%7%
 80–84 y11%(89%)15%(85%)14%16%10%17%17%13%11%
 85+ y17%(83%)20%(80%)19%22%16%23%23%19%17%
COPD
 66–69 y9%(91%)17%(83%)17%13%11%14%40%18%8%
 70–74 y10%(90%)18%(82%)18%15%12%15%43%20%10%
 75–79 y12%(88%)21%(79%)20%18%13%18%43%20%11%
 80–84 y14%(86%)21%(79%)20%18%13%19%41%19%14%
 85+ y14%(86%)19%(81%)18%17%12%18%36%18%14%
Diabetes
 66–69 y20%(80%)25%(75%)27%28%21%26%24%20%21%
 70–74 y23%(77%)27%(73%)28%30%24%26%26%23%23%
 75–79 y24%(76%)28%(72%)29%29%25%28%26%26%24%
 80–84 y23%(77%)27%(73%)28%28%24%25%25%24%24%
 85+ y20%(80%)23%(77%)23%23%21%21%22%22%21%
  • Abbreviations: CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; CRC, colorectal cancer.

  • aFor cancer survivors, comorbidities were identified prior to receiving a cancer diagnosis. See Materials and Methods for details.